Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan.

Teppei Hagino Hidehisa SaekiEita FujimotoNaoko Kanda

Published in: The Journal of dermatological treatment (2024)

Deucravacitinib for patients with psoriasis was well-tolerated and gave favorable therapeutic effects in the real-world practice. Deucravacitinib treatment rapidly reduced pruritus.

Keyphrases

clinical practice
primary care
early onset
high intensity
quality improvement
drug induced
replacement therapy
smoking cessation